CLC number: R28; R979.1
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 0000-00-00
Cited: 48
Clicked: 7245
RUAN Wen-jing, LAI Mao-de, ZHOU Jian-guang. Anticancer effects of Chinese herbal medicine, science or myth?[J]. Journal of Zhejiang University Science B, 2006, 7(12): 1006-1014.
@article{title="Anticancer effects of Chinese herbal medicine, science or myth?",
author="RUAN Wen-jing, LAI Mao-de, ZHOU Jian-guang",
journal="Journal of Zhejiang University Science B",
volume="7",
number="12",
pages="1006-1014",
year="2006",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.2006.B1006"
}
%0 Journal Article
%T Anticancer effects of Chinese herbal medicine, science or myth?
%A RUAN Wen-jing
%A LAI Mao-de
%A ZHOU Jian-guang
%J Journal of Zhejiang University SCIENCE B
%V 7
%N 12
%P 1006-1014
%@ 1673-1581
%D 2006
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.2006.B1006
TY - JOUR
T1 - Anticancer effects of Chinese herbal medicine, science or myth?
A1 - RUAN Wen-jing
A1 - LAI Mao-de
A1 - ZHOU Jian-guang
J0 - Journal of Zhejiang University Science B
VL - 7
IS - 12
SP - 1006
EP - 1014
%@ 1673-1581
Y1 - 2006
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.2006.B1006
Abstract: Currently there is considerable interest among oncologists to find anticancer drugs in chinese herbal medicine (CHM). In the past, clinical data showed that some herbs possessed anticancer properties, but western scientists have doubted the scientific validity of CHM due to the lack of scientific evidence from their perspective. Recently there have been encouraging results, from a western perspective, in the cancer research field regarding the anticancer effects of CHM. Experiments showed that CHM played its anticancer role by inducing apoptosis and differentiation, enhancing the immune system, inhibiting angiogenesis, reversing multidrug resistance (MDR), etc. Clinical trials demonstrated that CHM could improve survival, increase tumor response, improve quality of life, or reduce chemotherapy toxicity, although much remained to be determined regarding the objective effects of CHM in human in the context of clinical trials. Interestingly, both laboratory experiments and clinical trials have demonstrated that when combined with chemotherapy, CHM could raise the efficacy level and lower toxic reactions. These facts raised the feasibility of the combination of herbal medicines and chemotherapy, although much remained to be investigated in this area.
[1] Attele, A.S., Wu, J.A., Yuan, C.S., 1999. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol., 58(11):1685-1693.
[2] Cha, Y.Y., Lee, E.O., Lee, H.J., Park, Y.D., Ko, S.G., Kim, D.H., Kim, H.M., Kang, I.C., Kim, S.H., 2004. Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway. Clin. Chim. Acta, 348(1-2):41-48.
[3] Chan, T.Y., Tam, H.P., Lai, C.K., Chan, A.Y., 2005. A multidisciplinary approach to the toxicologic problems associated with the use of herbal medicines. Ther. Drug Monit., 27(1):53-57.
[4] Chen, G.Q., Zhu, J., Shi, X.G., Ni, J.H., Zhong, H.J., Si, G.Y., Jin, X.L., Tang, W., Li, X.S., Xong, S.M., et al., 1996. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood, 88(3):1052-1061.
[5] Chen, R.C., Su, J.H., Ouyang, G.L., Cai, K.X., Li, J.Q., Xie, X.G., 2002a. Induction of differentiation in human hepatocarcinoma cells by isoverbascoside. Planta Med., 68(4):370-372.
[6] Chen, Q., Peng, W., Qi, S., Xu, A., 2002b. Apoptosis of human highly metastatic lung cancer cell line 95-D induced by acutiaporberine, a novel bisalkaloid derived from Thalictrum acutifolium. Planta Med., 68(6):550-553.
[7] Cheng, Y.L., Chang, W.L., Lee, S.C., Liu, Y.G., Lin, H.C., Chen, C.J., Yen, C.Y., Yu, D.S., Lin, S.Z., Harn, H.J., 2003a. Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity. Life Sci., 73(18):2383-2394.
[8] Cheng, K.F., Leung, K.S., Leung, P.C., 2003b. Interactions between modern and Chinese medicinal drugs: a general review. Am. J. Chin. Med., 31(2):163-169.
[9] Efferth, T., Davey, M., Olbrich, A., Rucker, G., Gebhart, E., Davey, R., 2002. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol. Dis., 28(2):160-168.
[10] Frese, S., Pirnia, F., Miescher, D., Krajewski, S., Borner, M.M., Reed, J.C., Schmid, R.A., 2003. PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2. Oncogene, 22(35):5427-5435.
[11] Hayashi, I., Ohotsuki, M., Suzuki, I., Watanabe, T., 2001. Effects of oral administration of Echinacea purpurea (American herb) on incidence of spontaneous leukemia caused by recombinant leukemia viruses in AKR/J mice. Nihon Rinsho Meneki Gakkai Kaishi, 24(1):10-20.
[12] Hong-Fen, L., Waisman, T., Maimon, Y., Shakhar, K., Rosenne, E., Ben-Eliyahu, S., 2001. The effects of a Chinese herb formula, anti-cancer number one (ACNO), on NK cell activity and tumor metastasis in rats. Int. Immunopharmacol., 1(11):1947-1956.
[13] Hsieh, T.C., Lu, X., Guo, J., Xiong, W., Kunicki, J., Darzynkiewicz, Z., Wu, J.M., 2002. Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies. Int. J. Oncol., 20(4):681-689.
[14] Hsieh, C.C., Lin, W.C., Lee, M.R., Hsu, S.L., Liu, H.S., Kao, S.T., Hsieh, M.T., 2003. Dang-Gui-Bu-Xai-Tang modulated the immunity of tumor bearing mice. Immunopharmacol. Immunotoxicol., 25(2):259-271.
[15] Huang, Y.H., Zhang, S.H., Zhen, R.X., Xu, X.D., Zhen, Y.S., 2004. Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine. Ai Zheng, 23(12):1599-1604 (in Chinese).
[16] Huh, J.E., Kang, K.S., Ahn, K.S., Kim, D.H., Saiki, I., Kim, S.H., 2003. Mylabris phalerlata induces apoptosis by caspase activation following cytochrome c release and Bid cleavage. Life Sci., 73(17):2249-2262.
[17] Iizuka, N., Hazama, S., Yoshimura, K., Yoshino, S., Tangoku, A., Miyamoto, K., Okita, K., Oka, M., 2002. Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int. J. Cancer, 99(2):286-291.
[18] Ikezoe, T., Chen, S., Saito, T., Asou, H., Kyo, T., Tanosaki, S., Heber, D., Taguchi, H., Koeffler, H.P., 2003a. PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells. Int. J. Oncol., 23(4):1203-1211.
[19] Ikezoe, T., Chen, S.S., Yang, Y., Heber, D., Taguchi, H., Koeffler, H.P., 2003b. PC-SPES: molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. Int. J. Oncol., 23(5):1461-1470.
[20] Li, D.P., 2001. Progresses in basic studies of anticancer mechanisms of Kanglaite injection (KLT). Zhong Yao Xin Yao Yu Lin Chuang Yao Li, 12(2):122-124 (in Chinese).
[21] Lin, S.Y., Liu, J.D., Chang, H.C., Yeh, S.D., Lin, C.H., Lee, W.S., 2002. Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J. Cell Biochem., 84(3):532-544.
[22] Lin, J., Dong, H.F., Oppenheim, J.J., Howard, O.M., 2003. Effects of astragali radix on the growth of different cancer cell lines. World J. Gastroenterol., 9(4):670-673.
[23] Ma, J., Fu, N.Y., Pang, D.B., Wu, W.Y., Xu, A.L., 2001. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med., 67(8):754-757.
[24] Mabed, M., El-Helw, L., Shamaa, S., 2004. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma. Br. J. Cancer, 90(1):65-69.
[25] Oh, W.K., Kantoff, P.W., Weinberg, V., Jones, G., Rini, B.I., Derynck, M.K., Bok, R., Smith, M.R., Bubley, G.J., Rosen, R.T., et al., 2004. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J. Clin. Oncol., 22(18):3705-3712.
[26] Piao, B.K., Wang, Y.X., Xie, G.R., Mansmann, U., Matthes, H., Beuth, J., Lin, H.S., 2004. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res., 24(1):303-309.
[27] Plouzek, C.A., Ciolino, H.P., Clarke, R., Yeh, G.C., 1999. Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur. J. Cancer, 35(10):1541-1545.
[28] Powell, C.B., Fung, P., Jackson, J., Dall'Era, J., Lewkowicz, D., Cohen, I., Smith-McCune, K., 2003. Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines. Gynecol. Oncol., 91(2):332-340.
[29] Semiglasov, V.F., Stepula, V.V., Dudov, A., Lehmacher, W., Mengs, U., 2004. The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res., 24(2C):1293-1302.
[30] Shen, Z.X., Shi, Z.Z., Fang, J., Gu, B.W., Li, J.M., Zhu, Y.M., Shi, J.Y., Zheng, P.Z., Yan, H., Liu, Y.F., et al., 2004. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA, 101(15):5328-5335.
[31] Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar, S., Calleja, E., Dardashti, L.J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D.A., et al., 1998. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med., 339(19):1341-1348.
[32] Takeda, Y., Togashi, H., Matsuo, T., Shinzawa, H., Takeda, Y., Takahashi, T., 2001. Growth inhibition and apoptosis of gastric cancer cell lines by Anemarrhena asphodeloides Bunge. J. Gastroenterol., 36(2):79-90.
[33] Tsai, Y.J., Chen, I.L., Horng, L.Y., Wu, R.T., 2002. Induction of differentiation in rat C6 glioma cells with Saikosaponins. Phytother. Res., 16(2):117-121.
[34] Wartenberg, M., Budde, P., de Mareés, M., Grunheck, F., Tsang, S.Y., Huang, Y., Chen, Z.Y., Hescheler, J., Sauer, H., 2003. Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional chinese medicine. Lab. Invest., 83(1):87-98.
[35] Wheeler, R.H., Busby, L., Samlowski, W., Gerard, R., 2003. Phase I Study of Kanglaite (KLT) a Botanical Product Based on Traditional Chinese Medicine. Presented at American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL.
[36] Xue, T., Roy, R., 2003. Studying traditional Chinese medicine. Science, 300(5620):740-741.
[37] Yang, L.L., Lee, C.Y., Yen, K.Y., 2000. Induction of apoptosis by hydrolyzable tannins from Eugenia jambos L. on human leukemia cells. Cancer Lett., 157(1):65-75.
[38] Yeh, C.W., Chen, W.J., Chiang, C.T., Lin-Shiau, S.Y., Lin, J.K., 2003. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects. Pharmacogenomics J., 3(5):267-276.
[39] Zhang, D.Y., Wu, J., Ye, F., Xue, L., Jiang, S., Yi, J., Zhang, W., Wei, H., Sung, M., Wang, W., et al., 2003. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res., 63(14):4037-4043.
[40] Zhong, L., Chen, F., Han, J., Shao, N., Ouyang, R., 2003. Effects of red orpiment on cell morphology and expression of PML mRNA and protein in NB4 and HL-60 cells. Chin. Med. J., 116(1):148-150.
Open peer comments: Debate/Discuss/Question/Opinion
<1>